The knock-down of SGPL1 induced greater cytotoxicity against the highly SGPL1-expressing ovarian cancer cell line, RMG-I, in comparison to the poorly SGPL1-expressing cell line ES-2 (Supplemental Fig. S1b). The gene discussed is SGPL1; the disease is ovarian carcinoma.